Literature DB >> 1242749

Adverse drug reactions. A critical review.

F E Karch, L Lasagna.   

Abstract

The data on adverse drug reactions (ADRs) are incomplete, unrepresentative, uncontrolled, and lacking in operational criteria for identifying ADRs. No quantitative conclusions can be drawn from the reported data in regard to morbidity, mortality, or the underlying causes of ADRs, and attempts to extrapolate the available data to the general population would be invalid and perhaps misleading. To evaluate the impact as well as the causes of ADRs, representative populations, including general hospital and ambulatory patients of all medical specialties, must be studied, and operationally defined criteria must be used to establish the presence of an ADR in a prospective study that incorporates appropriate control populations. Similar studies on the benefits of drug use are needed to provide perspective on the risk-benefit aspects of drug therapy. Until such studies are performed, estimates of the nature and scope of the ADR problem can be only guesses.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1242749

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  120 in total

1.  Academic detailing improves identification and reporting of adverse drug events.

Authors:  R G Schlienger; T F Lüscher; R A Schoenenberger; W E Haefeli
Journal:  Pharm World Sci       Date:  1999-06

2.  Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand.

Authors:  Mira Harrison-Woolrych; Simran Maggo; Ming Tan; Ruth Savage; Janelle Ashton
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

3.  Adverse reactions to drugs as a cause of admissions to a general teaching hospital in Hong Kong.

Authors:  T Y Chan; J C Chan; B Tomlinson; J A Critchley
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 4.  Adverse reactions as a cause of hospital admission in the aged.

Authors:  K Beard
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

Review 5.  Evaluation of safety and tolerance in clinical trials with antimicrobial agents.

Authors:  H Lode; R Stahlmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

Review 6.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

7.  Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand.

Authors:  Mira Harrison-Woolrych; Janelle Ashton
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

8.  Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.

Authors:  L Weiner; G Frithz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

10.  Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin.

Authors:  M Levy; H Kewitz; W Altwein; J Hillebrand; M Eliakim
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.